Abstract

Objective. PG201 has been formulated using 12 herbs known to have anti‐inflammatory and protective effects on damaged tissue and bone among other functions. The present study was done in order to assess the therapeutic effects of PG201 in collagen‐induced arthritis (CIA) in mice. Methods. DBA/1 mice were immunized with bovine type II collagen. After a second collagen immunization, mice were treated with PG201 orally at 10 mg/kg once a day for 18 days. Paws were evaluated macroscopically for redness, swelling and deformities. The levels of TNF‐α and IL‐1β in the ankle were examined. The severity of arthritis within the knee joints was evaluated by histological assessment of cartilage destruction and pannus formation. Molecular indicators related to CIA pathology were analysed by measuring the serum levels of matrix metalloproteinase 2 (MMP‐2), tissue inhibitor of matrix metalloproteinase 2 (TIMP‐2) and the anti‐inflammatory cytokines interleukin (IL)‐4 and IL‐10. Results. Administration of PG201 significantly suppressed the progression of CIA and inhibited the production of TNF‐α and IL‐1β in the paws. The erosion of cartilage was dramatically reduced in mouse knees after treatment with PG201. In the serum of PG201‐treated mice, the level of TIMP‐2 and the ratio of TIMP‐2 to MMP‐2 were significantly elevated, and the level of IL‐4, but not of IL‐10, was increased. Conclusion. Administration of PG201 has therapeutic effects on CIA. Protection of cartilage was particularly prominent. PG201 is a potential therapy for rheumatoid arthritis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.